Science Explorer Interactive view Map
Company · South San Francisco · United States

Nkarta Therapeutics (United States)

nkartatx.comROR OpenAlex
Research works
34
▲ 290% vs 2013–17
Citations
362
10.7 per fractional work
Top-10% rate
7.6%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Nkarta Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Nkarta Therapeutics (United States)?

Ranked on the composite score, James Trager lead among researchers whose main affiliation is Nkarta Therapeutics (United States).

  1. 1 James Trager United States · #1,284,749 worldwide 20 citations · 17 works
All ranked researchers at Nkarta Therapeutics (United States)

Which keywords describe research at Nkarta Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Lymphoma, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Natural Killer Cells, NK Cell Recognition and Monoclonal Antibodies.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 17 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 17 words, with their numbers
  1. Cancer Immunotherapy10▲ 211×2 topics
  2. Lymphoma10▲ 197×2 topics
  3. Immunotherapy10▲ 44×2 topics
  4. CAR T Cells10▲ 651×1 topic
  5. Chimeric Antigen Receptor10▲ 651×1 topic
  6. NK Cell Recognition10▲ 278×1 topic
  7. Natural Killer Cells10▲ 278×1 topic
  8. Monoclonal Antibodies2▲ 36×3 topics
  9. Glycosylation2▲ 20×3 topics
  10. Immune Activation1▲ 42×2 topics
  11. Immune Response1▲ 6.2×3 topics
  12. Oxidative Stress1▲ 2.1×4 topics
  13. Antiretroviral Therapy1▲ 15×3 topics
  14. Epidemiology1◆ 0.90×5 topics
  15. Therapeutic Antibodies1▲ 27×2 topics
  16. Depression1▲ 4.0×2 topics
  17. Tumor Microenvironment1▲ 8.6×2 topics

Which research topics does Nkarta Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, Acute Myeloid Leukemia Research and Monoclonal and Polyclonal Antibodies Research.

CAR-T cell therapy resea…5CAR-T cell therapy research: 5 fractional worksImmune Cell Function and…5Immune Cell Function and Interaction: 5 fractional worksAcute Myeloid Leukemia Research: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksBiosimilars and Bioanalytical Methods: 1 fractional worksCRISPR and Genetic Engineering: 0 fractional worksLymphoma Diagnosis and Treatment: 0 fractional worksTea Polyphenols and Effects: 0 fractional worksMultiple Myeloma Research and Treatments: 0 fractional works
OncologyImmunologyHematologyRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 5 works
  2. 2 Immune Cell Function and Interaction Immunology 5 works
  3. 3 Acute Myeloid Leukemia Research Hematology 1 works
  4. 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  5. 5 Cancer Immunotherapy and Biomarkers Oncology 1 works
  6. 6 Biosimilars and Bioanalytical Methods Immunology 1 works
  7. 7 CRISPR and Genetic Engineering Molecular Biology 0 works
  8. 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
  9. 9 Tea Polyphenols and Effects Pathology and Forensic Medicine 0 works
  10. 10 Multiple Myeloma Research and Treatments Hematology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.0%not open58.0%

World: 28% of research is openly available.

with international co-authors15.7%domestic only84.3%

World: 19% is written across borders.

How has Nkarta Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 290% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.